Wecome Pharmaceutical Co Ltd (300878) — Cash Flow Quality Index
Wecome Pharmaceutical Co Ltd (300878) has a Cash Flow Quality Index of -0.51x as of September 2024. Operating cash flow of CN¥-15.34 Million is below net income of CN¥29.91 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore 300878 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Wecome Pharmaceutical Co Ltd Cash Flow Quality Index (2013–2022)
Historical Cash Flow Quality Index for Wecome Pharmaceutical Co Ltd across 10 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see 300878 cash flow conversion.
Annual Cash Flow Quality Index for Wecome Pharmaceutical Co Ltd (2013–2022)
Year-by-year earnings quality comparison for Wecome Pharmaceutical Co Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | 3.25x | CN¥146.57 Million | CN¥45.12 Million | ▲ +562.9% |
| 2021 | -0.70x | CN¥-67.74 Million | CN¥96.55 Million | ▼ -322.4% |
| 2020 | 0.32x | CN¥42.81 Million | CN¥135.70 Million | ▼ -64.7% |
| 2019 | 0.89x | CN¥112.76 Million | CN¥126.01 Million | ▼ -25.6% |
| 2018 | 1.20x | CN¥105.57 Million | CN¥87.78 Million | ▲ +294.6% |
| 2017 | 0.30x | CN¥29.00 Million | CN¥95.16 Million | ▼ -75.4% |
| 2016 | 1.24x | CN¥100.15 Million | CN¥80.85 Million | ▲ +109.1% |
| 2015 | 0.59x | CN¥29.63 Million | CN¥50.02 Million | ▼ -75.8% |
| 2014 | 2.45x | CN¥46.01 Million | CN¥18.77 Million | ▲ +35.7% |
| 2013 | 1.81x | CN¥25.98 Million | CN¥14.38 Million | — |